{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:47:34Z","timestamp":1784238454893,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D projects of sichuan provincial science and technology department","award":["2024YFFK0366, 2024YFFK0076"],"award-info":[{"award-number":["2024YFFK0366, 2024YFFK0076"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-08672-7","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:07:00Z","timestamp":1769105220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The diagnostic and prognostic values of non-criteria antiphospholipid antibodies in obstetric antiphospholipid syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinbiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1745-9283","authenticated-orcid":false,"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"4","key":"8672_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11239-023-02789-8","volume":"55","author":"JJ Tao","year":"2023","unstructured":"Tao JJ, Adurty S, D\u2019Angelo D, DeSancho MT. Management and outcomes of women with antiphospholipid syndrome during pregnancy. J Thromb Thrombolysis. 2023;55(4):751\u20139.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"8672_CR2","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/ijms24043195","volume":"24","author":"S D\u2019Ippolito","year":"2023","unstructured":"D\u2019Ippolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G, Di Simone N. Antiphospholipid syndrome in pregnancy: new and old pathogenetic mechanisms. Int J Mol Sci. 2023;24(4):3195.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8672_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12884-025-07471-w","volume":"25","author":"VR Murvai","year":"2025","unstructured":"Murvai VR, Gali\u0219 R, Panaitescu A, Radu CM, Ghitea TC, Trif P, et al. Antiphospholipid syndrome in pregnancy: a comprehensive literature review. BMC Pregnancy Childbirth. 2025;25(1):337.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"8672_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost JTH. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost JTH"},{"issue":"10","key":"8672_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol Hoboken NJ. 2023;75(10):1687\u2013702.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"3","key":"8672_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/jcm11030675","volume":"11","author":"J Alijotas-Reig","year":"2022","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Anunciaci\u00f3n-Llunell A, Marques-Soares J, Pardos-Gea J, Mir\u00f3-Mur F. Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: A comprehensive review. J Clin Med. 2022;11(3):675.","journal-title":"J Clin Med"},{"issue":"4","key":"8672_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/jcm14041299","volume":"14","author":"S Be\u00e7a","year":"2025","unstructured":"Be\u00e7a S, Borrell M, Cervera R, Figueras F, Nadal A, Espinosa G, et al. Non-Criteria obstetric antiphospholipid syndrome: myth or reality? J Clin Med. 2025;14(4):1299.","journal-title":"J Clin Med"},{"key":"8672_CR8","doi-asserted-by":"crossref","unstructured":"Liu H, Han J, Gao R, Hu Z, Tang Y, Qin L. Clinical features between primary obstetric antiphospholipid syndrome and Non-Criteria obstetric antiphospholipid syndrome and risk factors of adverse pregnancy outcomes: A retrospective study of 1006 Cases. Am J reprod Immunol N Y N 1989. 2024 Sept;92(3):e13931.","DOI":"10.1111\/aji.13931"},{"issue":"2","key":"8672_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jtha.2024.10.022","volume":"23","author":"KMJ Devreese","year":"2025","unstructured":"Devreese KMJ, Bertolaccini ML, Branch DW, de Laat B, Erkan D, Favaloro EJ, et al. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC subcommittee on lupus Anticoagulant\/Antiphospholipid antibodies. J Thromb Haemost JTH. 2025;23(2):731\u201344.","journal-title":"J Thromb Haemost JTH"},{"issue":"11","key":"8672_CR10","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1590\/1806-9282.66.11.1595","volume":"66","author":"A Funke","year":"2020","unstructured":"Funke A, Staub HL, Monticielo OA, Balbi GGM, Danowski A, Santiago MB, et al. Non-criteria antiphospholipid antibodies: a narrative review. Rev Assoc Med Bras 1992. 2020;66(11):1595\u2013601.","journal-title":"Rev Assoc Med Bras 1992"},{"issue":"2","key":"8672_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/keab414","volume":"61","author":"S Truglia","year":"2022","unstructured":"Truglia S, Mancuso S, Capozzi A, Recalchi S, Riitano G, Longo A, et al. Non-criteria antiphospholipid antibodies\u2019: bridging the gap between seropositive and seronegative antiphospholipid syndrome. Rheumatol Oxf Engl. 2022;61(2):826\u201333.","journal-title":"Rheumatol Oxf Engl"},{"key":"8672_CR12","doi-asserted-by":"publisher","first-page":"972012","DOI":"10.3389\/fimmu.2022.972012","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Zhu L, Liu H, Cai Q, Yun Z, Sun F, et al. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: diagnostic value added. Front Immunol. 2022;13:972012.","journal-title":"Front Immunol"},{"issue":"3","key":"8672_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3324\/haematol.2019.221945","volume":"105","author":"P Pignatelli","year":"2020","unstructured":"Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F, Pastori D. Seronegative antiphospholipid syndrome: refining the value of \u2018non-criteria\u2019 antibodies for diagnosis and clinical management. Haematologica. 2020;105(3):562\u201372.","journal-title":"Haematologica"},{"issue":"SI","key":"8672_CR14","doi-asserted-by":"publisher","first-page":"SI64","DOI":"10.1093\/rheumatology\/kead632","volume":"63","author":"B de Laat","year":"2024","unstructured":"de Laat B, Gehlen R, de Groot PG, Viewpoint. The value of non-criteria antiphospholipid antibodies. Rheumatol Oxf Engl. 2024;63(SI):SI64\u201371.","journal-title":"Rheumatol Oxf Engl"},{"issue":"21","key":"8672_CR15","doi-asserted-by":"publisher","first-page":"12819","DOI":"10.3390\/ijms232112819","volume":"23","author":"A Anunciaci\u00f3n-Llunell","year":"2022","unstructured":"Anunciaci\u00f3n-Llunell A, Mu\u00f1oz C, Roggenbuck D, Frasca S, Pardos-Gea J, Esteve-Valverde E, et al. Differences in antiphospholipid antibody profile between patients with obstetric and thrombotic antiphospholipid syndrome. Int J Mol Sci. 2022;23(21):12819.","journal-title":"Int J Mol Sci"},{"key":"8672_CR16","doi-asserted-by":"crossref","unstructured":"Zhang X, Liu Z, Guo F, Wang Q, Bai W, Zhao A. Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) and risk of obstetric anti-phospholipid syndrome. Am J Reprod Immunol. 2023 June;89(6):e13621.","DOI":"10.1111\/aji.13621"},{"key":"8672_CR17","doi-asserted-by":"crossref","unstructured":"Vandevelde A, Gris JC, Moore GW, Musia\u0142 J, Zuily S, Wahl D, et al. Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC subcommittee on lupus Anticoagulant\/Antiphospholipid antibodies. J Thromb Haemost JTH. 2023 July;21(7):1981\u201394.","DOI":"10.1016\/j.jtha.2023.04.001"},{"issue":"1","key":"8672_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1160\/TH14-05-0416","volume":"113","author":"DRJ Arachchillage","year":"2015","unstructured":"Arachchillage DRJ, Machin SJ, Mackie IJ, Cohen H. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome. Thromb Haemost. 2015;113(1):13\u20139.","journal-title":"Thromb Haemost"},{"key":"8672_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-1-0716-3175-1_15","volume":"2663","author":"EJ Favaloro","year":"2023","unstructured":"Favaloro EJ, Pasalic L. An overview of laboratory testing for antiphospholipid antibodies. Methods Mol Biol Clifton NJ. 2023;2663:253\u201362.","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"Suppl 1","key":"8672_CR20","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.medcli.2024.05.001","volume":"163","author":"A Soto-Peleteiro","year":"2024","unstructured":"Soto-Peleteiro A, Gonzalez-Echavarri C, Ruiz-Irastorza G. Obstetric antiphospholipid syndrome. Med Clin (Barc). 2024;163(Suppl 1):S14\u201321.","journal-title":"Med Clin (Barc)"},{"key":"8672_CR21","doi-asserted-by":"crossref","unstructured":"Gris JC, Guillotin F, Ch\u00e9a M, Bourguignon C, Nouvellon \u00c9, Bouvier S. Antiphospholipid antibodies in pregnancy: maternal and neonatal implications. Semin Thromb Hemost. 2023 June;49(4):337\u201347.","DOI":"10.1055\/s-0042-1756193"},{"issue":"11","key":"8672_CR22","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1093\/rheumatology\/kev226","volume":"54","author":"V Rodr\u00edguez-Garc\u00eda","year":"2015","unstructured":"Rodr\u00edguez-Garc\u00eda V, Ioannou Y, Fern\u00e1ndez-Nebro A, Isenberg DA, Giles IP. Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. Rheumatol Oxf Engl. 2015;54(11):2042\u201350.","journal-title":"Rheumatol Oxf Engl"},{"key":"8672_CR23","doi-asserted-by":"publisher","first-page":"741369","DOI":"10.3389\/fimmu.2021.741369","volume":"12","author":"C Hu","year":"2021","unstructured":"Hu C, Li S, Xie Z, You H, Jiang H, Shi Y, et al. Evaluation of the diagnostic value of Non-criteria antibodies for antiphospholipid syndrome patients in a Chinese cohort. Front Immunol. 2021;12:741369.","journal-title":"Front Immunol"},{"key":"8672_CR24","doi-asserted-by":"crossref","unstructured":"Mattia E, Ruffatti A, Tonello M, Meneghel L, Robecchi B, Pittoni M, et al. IgA anticardiolipin and IgA anti-\u03b22 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome. Clin Chem Lab Med. 2014 Sept;52(9):1329\u201333.","DOI":"10.1515\/cclm-2014-0039"},{"key":"8672_CR25","doi-asserted-by":"publisher","first-page":"1541165","DOI":"10.3389\/fimmu.2025.1541165","volume":"16","author":"L Li","year":"2025","unstructured":"Li L, Chen J, Feng J, Zhao H, Liu X, Jiang Y. Anti-\u03b22 glycoprotein domain 1 antibody as a diagnostic marker for antiphospholipid syndrome and a predictor of thrombosis: a systematic review and meta-analysis. Front Immunol. 2025;16:1541165.","journal-title":"Front Immunol"},{"issue":"2","key":"8672_CR26","doi-asserted-by":"publisher","first-page":"e000924","DOI":"10.1136\/lupus-2023-000924","volume":"10","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Hu C, Qi W, Long Y, Huang C, Wang Q, et al. Anti-\u03b22GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China. Lupus Sci Med. 2023;10(2):e000924.","journal-title":"Lupus Sci Med"},{"key":"8672_CR27","doi-asserted-by":"crossref","unstructured":"De Craemer AS, Musial J, Devreese KMJ. Role of anti-domain 1-\u03b22 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome. J Thromb Haemost JTH. 2016 Sept;14(9):1779\u201387.","DOI":"10.1111\/jth.13389"},{"key":"8672_CR28","doi-asserted-by":"crossref","unstructured":"Chighizola CB, Pregnolato F, Andreoli L, Bodio C, Cesana L, Comerio C, et al. Beyond thrombosis: Anti-\u03b22GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome. J Autoimmun. 2018 June;90:76\u201383.","DOI":"10.1016\/j.jaut.2018.02.002"},{"issue":"1","key":"8672_CR29","first-page":"55","volume":"145","author":"KA Moyle","year":"2025","unstructured":"Moyle KA, Branch DW, Peterson LK, Guerra MM, Allshouse AA, Benson AE, et al. Association between novel antiphospholipid antibodies and adverse pregnancy outcomes. Obstet Gynecol. 2025;145(1):55\u201364.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"8672_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10238-019-00555-w","volume":"19","author":"H Guo","year":"2019","unstructured":"Guo H, Zhang Y, Li A, Wang C, Yang S, Zhang Y, et al. Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients. Clin Exp Med. 2019;19(3):339\u201345.","journal-title":"Clin Exp Med"},{"key":"8672_CR31","doi-asserted-by":"crossref","unstructured":"Zhu R, Cheng CY, Yang Y, Denas G, Pengo V. Prevalence of aPhosphatidylserine\/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis. Thromb Res. 2022 June;214:106\u201314.","DOI":"10.1016\/j.thromres.2022.04.021"},{"issue":"2","key":"8672_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10067-016-3498-0","volume":"36","author":"L Zhu","year":"2017","unstructured":"Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, et al. Diagnostic value of antibodies to phosphatidylserine\/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol. 2017;36(2):401\u20136.","journal-title":"Clin Rheumatol"},{"key":"8672_CR33","doi-asserted-by":"crossref","unstructured":"Pham M, Orsolini G, Crowson C, Snyder M, Pruthi R, Moder K. Anti-phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all-comer population. J Thromb Haemost JTH. 2022 Sept;20(9):2070\u20134.","DOI":"10.1111\/jth.15792"},{"key":"8672_CR34","doi-asserted-by":"publisher","first-page":"975704","DOI":"10.1155\/2015\/975704","volume":"2015","author":"P \u017digon","year":"2015","unstructured":"\u017digon P, Perdan Pirkmajer K, Tom\u0161i\u010d M, Kveder T, Bo\u017ei\u010d B, Sodin \u0160emrl S, et al. Anti-Phosphatidylserine\/Prothrombin antibodies are associated with adverse pregnancy outcomes. J Immunol Res. 2015;2015:975704.","journal-title":"J Immunol Res"},{"issue":"4","key":"8672_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1055\/s-0040-1705115","volume":"120","author":"M Radin","year":"2020","unstructured":"Radin M, Foddai SG, Cecchi I, Rubini E, Schreiber K, Roccatello D, et al. Antiphosphatidylserine\/Prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome. Thromb Haemost. 2020;120(4):592\u20138.","journal-title":"Thromb Haemost"},{"key":"8672_CR36","doi-asserted-by":"crossref","unstructured":"Tripodi A, Cohen H, Devreese KMJ. Lupus anticoagulant detection in anticoagulated patients. Guidance from the scientific and standardization committee for lupus anticoagulant\/antiphospholipid antibodies of the international society on thrombosis and haemostasis. J Thromb Haemost JTH. 2020 July;18(7):1569\u201375.","DOI":"10.1111\/jth.14846"},{"key":"8672_CR37","doi-asserted-by":"publisher","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","volume":"380","author":"JS Knight","year":"2023","unstructured":"Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ. 2023;380:e069717.","journal-title":"BMJ"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08672-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:03:32Z","timestamp":1771293812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08672-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8672"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08672-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was approved by the Ethics Committee\/Institutional Review Board of West China Second University Hospital (Approval No. 2024-034). And this study complies with the Declaration of Helsinki. Informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}